Literature DB >> 35107650

Bacteremia after hepatectomy and biliary reconstruction for biliary cancer: the characteristics of bacteremia according to occurrence time and associated complications.

Junki Fukuda1, Kimitaka Tanaka2, Aya Matsui1, Yoshitsugu Nakanishi1, Toshimichi Asano1, Takehiro Noji1, Toru Nakamura1, Takahiro Tsuchikawa1, Keisuke Okamura1, Satoshi Hirano1.   

Abstract

PURPOSE: Bacteremia occurring after extensive hepatic resection and biliary reconstruction (Hx + Bx) for biliary cancer is a critical infectious complication. This study evaluated postoperative bacteremia and examined the potential usefulness of surveillance cultures.
METHODS: We retrospectively reviewed 179 patients who underwent Hx + Bx for biliary cancer from January 2008 to December 2018 in our department.
RESULTS: Bacteremia occurred in 41 (23.0%) patients. Patients with bacteremia had a longer operation time and more frequent intraoperative transfusion and more frequently developed organ/space surgical site infection (SSI) than those without bacteremia. The most frequently isolated bacterial species from blood cultures were Enterococcus faecium (29.3%), Enterobacter cloacae (24.4%), and Enterococcus faecalis (22.0%). The SIRS duration of bacteremia associated with organ/space SSI was significantly longer than that of other infectious complications (median 96 h vs. 48 h; p = 0.043). Bacteremia associated with organ/space SSI occurred most often by postoperative day (POD) 30. The concordance rate of bacterial species between blood and surveillance cultures within POD 30 was 67-82%.
CONCLUSIONS: Bacteremia associated with organ/space SSI required treatment for a long time and typically occurred by POD 30. Postoperative surveillance cultures obtained during this period may be useful for selecting initial antibiotic therapy because of their high concordance rate with blood cultures.
© 2022. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Bacteremia; Biliary cancer; Biliary reconstruction; Hepatectomy; Surveillance culture

Mesh:

Year:  2022        PMID: 35107650     DOI: 10.1007/s00595-022-02462-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.540


  1 in total

1.  Clinical and oncological benefits of left hepatectomy for Bismuth type I/II perihilar cholangiocarcinoma.

Authors:  Yoshitsugu Nakanishi; Satoshi Hirano; Keisuke Okamura; Takahiro Tsuchikawa; Toru Nakamura; Takehiro Noji; Toshimichi Asano; Aya Matsui; Kimitaka Tanaka; Soichi Murakami; Yuma Ebihara; Yo Kurashima; Yusuke Watanabe; Toshiaki Shichinohe
Journal:  Surg Today       Date:  2021-11-01       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.